Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INTRAPLEURAL
STATUS: Approved
THERAPEUTIC AREA: OTHER; RESPIRATORY
THERAPEUTIC INDICATION: Carcinoma, Non-Small-Cell Lung; Osteoarthritis, Hip; Osteoarthritis, Knee; Radius Fractures; Pleural Effusion
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alzheimer Disease; Endometrial Neoplasms; Menopause; Severe Acute Respiratory Syndrome; Bone Diseases, Metabolic; Breast Neoplasms; Osteoporosis; Osteoporosis, Postmenopausal; Polycystic Ovary Syndrome; Psychotic Disorders; Schizophrenia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Alcohol dehydrogenase class I inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER; PHARMACOLOGY
THERAPEUTIC INDICATION: Macular Degeneration
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alcoholism; Cocaine-Related Disorders; Sleep Apnea, Obstructive; Anxiety; Schizophrenia; Epilepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sulfonylurea receptor 1, Kir6.2 blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Gastrointestinal Stromal Tumors; Malaria; Mitochondrial Diseases; Parkinson Disease; Prostatic Neoplasms, Castration-Resistant; Atherosclerosis; Coronary Disease; Cystic Fibrosis; Hypercholesterolemia; Hypertension; Diabetes Mellitus; Diabetes Mellitus, Type 2
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D2 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Lecithin Cholesterol Acyltransferase Deficiency; Multiple Sclerosis; Alcoholism; Anxiety; Anxiety Disorders; Borderline Personality Disorder; Dementia; Depressive Disorder; Neurotic Disorders; Obsessive-Compulsive Disorder; Phobia, Social; Psychomotor Agitation; Psychotic Disorders; Stress Disorders, Post-Traumatic; Bipolar Disorder; Depressive Disorder, Major; Schizophrenia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Cocaine-Related Disorders; Dyskinesia, Drug-Induced; Renal Insufficiency, Chronic; Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Depression, Postpartum; Marijuana Abuse; Obsessive-Compulsive Disorder; Parkinson Disease; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Anxiety; Bipolar Disorder; Borderline Personality Disorder; Delirium; Dementia; Depressive Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Mental Disorders; Mood Disorders; Phobia, Social; Schizophrenia; Psychotic Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Fibromyalgia; Nausea
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: ENT; OTHER; PHARMACOLOGY; RESPIRATORY
THERAPEUTIC INDICATION: Mastitis; Bacterial Infections; Bronchitis, Chronic; Infections; Otitis Media; Pharyngitis; Pneumonia; Tonsillitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Central Nervous System Neoplasms; Glioblastoma; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Carcinoma, Renal Cell; Colorectal Neoplasms; Glioblastoma; Glioma; Lung Neoplasms; Lymphoma; Neoplasms; Pancreatic Neoplasms; Sepsis; Uterine Cervical Neoplasms; Vulvar Neoplasms; Carcinoma, Non-Small-Cell Lung; Lupus Erythematosus, Systemic; Multiple Myeloma; Uterine Cervical Dysplasia; Acquired Immunodeficiency Syndrome; Carcinoma; Diarrhea; HIV Infections; Virus Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Headache; Migraine Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: CANCER; OTHER
THERAPEUTIC INDICATION: Carcinoma, Merkel Cell; Central Nervous System Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Neoplasm Metastasis; Urinary Bladder Neoplasms; Anus Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Neuroendocrine; Fallopian Tube Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hypopharyngeal Neoplasms; Inflammatory Breast Neoplasms; Kidney Neoplasms; Lung Neoplasms; Mesothelioma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pseudomyxoma Peritonei; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Biliary Tract Neoplasms; Brain Diseases; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Hand-Foot Syndrome; Liver Neoplasms; Nasopharyngeal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Colonic Neoplasms; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Acute Coronary Syndrome; Child Development Disorders, Pervasive; Alcoholism; Bipolar Disorder; Cocaine-Related Disorders; Irritable Bowel Syndrome; Opioid-Related Disorders; Panic Disorder; Parkinson Disease; Anxiety; Dementia; Depressive Disorder, Major; Obsessive-Compulsive Disorder; Psychomotor Agitation; Schizophrenia; Stroke; Depressive Disorder
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Type-1 angiotensin II receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR; DIABETES DRUGS & ENDOCRINOLOGY; OTHER
THERAPEUTIC INDICATION: Pain; Severe Acute Respiratory Syndrome; Atherosclerosis; Breast Neoplasms; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Essential Hypertension; Hypercholesterolemia; Hypertension, Renovascular; Proteinuria; Renal Artery Obstruction; Angina Pectoris; Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dihydroorotate dehydrogenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER; RHEUMATOLOGY
THERAPEUTIC INDICATION: Breast Neoplasms; HIV Infections; Melanoma; Neoplasms; IgA Vasculitis; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Multiple Myeloma; Pemphigoid, Bullous; Prostatic Neoplasms, Castration-Resistant; Sjogren's Syndrome; Smoldering Multiple Myeloma; Uveitis; Arthritis, Psoriatic; Central Nervous System Neoplasms; Lupus Nephritis; Myasthenia Gravis; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Immune System Diseases; Multiple Sclerosis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Migraine with Aura; Migraine without Aura; Migraine Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hepatitis C; Acidosis, Lactic; Lipodystrophy; Sarcoma, Kaposi; Acquired Immunodeficiency Syndrome; Amyotrophic Lateral Sclerosis; HIV Infections; Tuberculosis; Virus Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Neuralgia; Kidney Calculi; Low Back Pain; Pain; Pelvic Organ Prolapse; Urinary Bladder, Overactive; Polyuria; Urinary Incontinence
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Carbonic anhydrase II inhibitor
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Central Serous Chorioretinopathy; Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INTRAVESICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Carcinoma in Situ; Urinary Bladder Neoplasms; Carcinoma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Acute Kidney Injury; Anemia, Sickle Cell; Brain Diseases; Coronary Disease; Heart Diseases; Hepatitis C; Hypoxia-Ischemia, Brain; Infertility, Female; Ischemic Stroke; Liver Cirrhosis; Lymphangioma; Mycobacterium Infections; Myelodysplastic Syndromes; Pulmonary Embolism; Severe Acute Respiratory Syndrome; Urinary Incontinence; Brain Injuries; Bronchopulmonary Dysplasia; Carcinoma, Non-Small-Cell Lung; Cerebral Small Vessel Diseases; Cystic Fibrosis; Fetal Growth Retardation; Hypoplastic Left Heart Syndrome; Infertility; Muscular Dystrophy, Duchenne; Parkinson Disease; Pre-Eclampsia; Pregnancy; Premature Birth; Priapism; Prostatic Hyperplasia; Raynaud Disease; Scleroderma, Localized; Sexual Dysfunction, Physiological; Skin Ulcer; Arterial Occlusive Diseases; Coronary Vasospasm; Diabetes Mellitus; Eisenmenger Complex; Glaucoma; Heart Failure; Hypertension; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Lung Diseases; Peripheral Arterial Disease; Persistent Fetal Circulation Syndrome; Scleroderma, Systemic; Erectile Dysfunction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Catechol O-methyltransferase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: Cocaine-Related Disorders; Neuroblastoma; Alcoholism; Brain Injuries; Gambling; Obsessive-Compulsive Disorder; Pick Disease of the Brain; Schizophrenia; Tobacco Use Disorder; Liver Failure; Parkinson Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: CRL4(CRBN) E3 ubiquitin ligase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; OTHER
THERAPEUTIC INDICATION: Amyloidosis; Endometriosis; Epilepsy; Scleroderma, Systemic; Stomach Neoplasms; Acquired Immunodeficiency Syndrome; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Appendiceal Neoplasms; Brain Stem Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Castleman Disease; Central Nervous System Neoplasms; Cholangitis, Sclerosing; Colonic Neoplasms; Esophageal Neoplasms; Glioblastoma; Glioma; HIV Infections; HIV Wasting Syndrome; Head and Neck Neoplasms; Hepatitis C; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Immunoglobulin Light-chain Amyloidosis; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lupus Erythematosus, Discoid; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Medulloblastoma; Melanoma; Mouth Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Ovarian Neoplasms; Pain; Pancreatitis, Chronic; Primary Myelofibrosis; Proctitis; Prostatic Neoplasms; Psoriasis; Purpura, Thrombocytopenic, Idiopathic; Retroviridae Infections; Sarcoma; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Thalassemia; Waldenstrom Macroglobulinemia; beta-Thalassemia; Amyloidosis, Familial; Carcinoma, Hepatocellular; Carcinoma, Ovarian Epithelial; Colitis, Ulcerative; Colorectal Neoplasms; Cough; Crohn Disease; Fallopian Tube Neoplasms; Granuloma, Lethal Midline; Hypoalbuminemia; Idiopathic Pulmonary Fibrosis; Kidney Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Myelodysplastic Syndromes; Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoidosis; Vascular Malformations; Immune System Diseases; Multiple Myeloma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Renal Insufficiency; Ischemic Stroke; Pneumonia, Viral; Respiratory Insufficiency; Severe Acute Respiratory Syndrome; Stroke; Venous Thromboembolism; Acute Coronary Syndrome; Coronary Disease; Myocardial Infarction; Thrombosis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Type-1 angiotensin II receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER; PREGNANCY AND GYNECOLOGY
THERAPEUTIC INDICATION: Alzheimer Disease; HIV Infections; Neuralgia; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Essential Hypertension; Heart Diseases; Lipid Metabolism Disorders; Polycystic Kidney Diseases; Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome; Cardiovascular Diseases; Diabetes Mellitus; Hypertension; Myocardial Infarction; Stroke
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial DNA-directed RNA polymerase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: RESPIRATORY
THERAPEUTIC INDICATION: HIV Infections; Tuberculosis, Pulmonary; Tuberculosis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bronchopulmonary Dysplasia; HIV Infections; Immune System Diseases; Non-alcoholic Fatty Liver Disease; Respiratory Tract Diseases; Alzheimer Disease; Anemia, Sickle Cell; Cough; Leukemia, Myeloid, Acute; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premature Birth; Severe Dengue; Sleep Apnea Syndromes; Status Asthmaticus; Arthritis, Rheumatoid; Diabetic Nephropathies; Eosinophilic Esophagitis; Pain; Respiratory Sounds; Rhinitis, Allergic, Perennial; Severe Acute Respiratory Syndrome; Sleep Apnea, Obstructive; Asthma; Asthma, Exercise-Induced; Lung Diseases, Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Vitamin D receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS; ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER; UROLOGY AND KIDNEY
THERAPEUTIC INDICATION: Breast Neoplasms; Multiple Myeloma; Neoplasms; Rectal Neoplasms; Carcinoma, Pancreatic Ductal; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypocalcemia; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Albuminuria; Glomerulonephritis, IGA; Hyperparathyroidism; Hypertrophy, Left Ventricular; Kidney Diseases; Proteinuria; Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Cyclooxygenase-2 inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Breast Carcinoma In Situ; Carcinoma, Hepatocellular; Hepatolenticular Degeneration; Hypotension, Orthostatic; Inflammation; Keratosis, Actinic; Mouth Neoplasms; Myeloproliferative Disorders; Neuroblastoma; Tuberculosis; Uterine Cervical Neoplasms; Amyotrophic Lateral Sclerosis; Back Pain; Brain Neoplasms; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Cerebral Hemorrhage; Cervical Intraepithelial Neoplasia; Esophageal Neoplasms; Facial Pain; Glioblastoma; Glioma; Graves Ophthalmopathy; Hepatitis B, Chronic; Lymphangioleiomyomatosis; Medulloblastoma; Melanoma; Multiple Myeloma; Muscular Atrophy, Spinal; Neuralgia; Neurofibromatosis 1; Obsessive-Compulsive Disorder; Ovarian Neoplasms; Papilloma; Papillomavirus Infections; Paraproteinemias; Peritoneal Neoplasms; Pre-Eclampsia; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rotator Cuff Injuries; Sarcoma; Schizophrenia; Severe Acute Respiratory Syndrome; Squamous Cell Carcinoma of Head and Neck; Squamous Intraepithelial Lesions; Stomatitis; Temporomandibular Joint Disorders; Tonsillitis; Toothache; Urinary Bladder Neoplasms; Uterine Neoplasms; Adenoma; Alzheimer Disease; Bipolar Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Chronic Pain; Colonic Neoplasms; Colorectal Neoplasms; Depression, Postpartum; Depressive Disorder; Gout; Hand-Foot Syndrome; Head and Neck Neoplasms; Hypertension; Influenza, Human; Liver Neoplasms; Low Back Pain; Lung Neoplasms; Macular Degeneration; Memory Disorders; Nasopharyngeal Neoplasms; Osteoarthritis, Hip; Osteoarthritis, Knee; Pancreatic Neoplasms; Pharyngitis; Rectal Neoplasms; Tobacco Use Disorder; Wounds and Injuries; Acute Pain; Adenomatous Polyposis Coli; Arthritis, Juvenile; Arthritis, Rheumatoid; Dysmenorrhea; Hemorrhage; Migraine Disorders; Neoplasms; Osteoarthritis; Pain; Peptic Ulcer; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Stroke
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Chronic Kidney Disease-Mineral and Bone Disorder; Fibrous Dysplasia of Bone; Lung Neoplasms; Menopause; Back Pain; Bone Diseases, Metabolic; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Spinal Cord Injuries; Bone Diseases